
Sign up to save your podcasts
Or


Introducing Leading Through Setbacks with Cytokinetics’ Robert Blum from Clinical Trialblazers.
Follow the show: Clinical Trialblazers
In this episode of Clinical Trial Blazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on muscle biology. Robert shares the values that guide his leadership style and how to move forward after failing.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
By Adam Graham4.4
7272 ratings
Introducing Leading Through Setbacks with Cytokinetics’ Robert Blum from Clinical Trialblazers.
Follow the show: Clinical Trialblazers
In this episode of Clinical Trial Blazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on muscle biology. Robert shares the values that guide his leadership style and how to move forward after failing.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].

1,959 Listeners

192 Listeners

521 Listeners

270 Listeners

1,066 Listeners

419 Listeners

256 Listeners

384 Listeners

943 Listeners

39 Listeners

450 Listeners

13 Listeners

718 Listeners

374 Listeners

326 Listeners

42 Listeners

38 Listeners

13 Listeners

18 Listeners

5 Listeners

6 Listeners

25 Listeners

42 Listeners

30 Listeners

9 Listeners

241 Listeners

9 Listeners

202 Listeners

5 Listeners

17 Listeners

38 Listeners

4 Listeners